183 related articles for article (PubMed ID: 7331843)
1. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
Parent M; Toussaint C; Driesens F; Gelders Y
Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
[No Abstract] [Full Text] [Related]
2. Influence of route of administration on haloperidol plasma levels in psychotic patients.
Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P
Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the efficacy of haloperidol decanoate].
Alvarez JV; Li Gambi M
Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
[TBL] [Abstract][Full Text] [Related]
4. [Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].
Lemperiere T; Ropert R; Leger JM; Alexandre JY; Clerc G; Darondel A; Delaunay J; Delteil P; Malauzat D; Raynaud J
Encephale; 1984; 10(5):217-22. PubMed ID: 6519017
[TBL] [Abstract][Full Text] [Related]
5. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R
Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339
[No Abstract] [Full Text] [Related]
6. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
[TBL] [Abstract][Full Text] [Related]
7. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
[TBL] [Abstract][Full Text] [Related]
8. Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics.
Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Hu WH; Chien CP; Lam YF; Jann MW
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):105-12. PubMed ID: 8416597
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study.
Deberdt R; Elens P; Berghmans W; Heykants J; Woestenborghs R; Driesens F; Reyntjens A; van Wijngaarden I
Acta Psychiatr Scand; 1980 Oct; 62(4):356-63. PubMed ID: 7468294
[TBL] [Abstract][Full Text] [Related]
10. Plasma haloperidol levels and clinical response: confounding variables.
Mavroidis ML; Garver DL; Kanter DR; Hirschowitz J
Psychopharmacol Bull; 1985; 21(1):62-5. PubMed ID: 3983340
[No Abstract] [Full Text] [Related]
11. [Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients].
Marchant N; Caruso S; Cuervo L; Brizuela A
Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):37-41. PubMed ID: 2864788
[TBL] [Abstract][Full Text] [Related]
12. [Open clinical trial with haloperidol decanoate in patients with psychotic disorders].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1987 Jun; 33(2):157-62. PubMed ID: 3321918
[TBL] [Abstract][Full Text] [Related]
13. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
Greger J; Glitschka A; Müller K
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
[No Abstract] [Full Text] [Related]
14. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
Giraud-Serio J; Goyot C; Debray Q; Plaisant O; Grenier J; Pélicier Y
Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
De Cuyper H; Bollen J; van Praag HM; Verstraeten D
Br J Psychiatry; 1986 May; 148():560-6. PubMed ID: 2877701
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
arap Mengech HN; Wazome EG
East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
[No Abstract] [Full Text] [Related]
17. Correlates of early neuroleptic response using a uniform haloperidol dose.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N
Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
[TBL] [Abstract][Full Text] [Related]
18. [Use of very high doses of haloperidol in the treatment of acute psychotic episodes. Clinical and pharmacokinetic analysis apropos of 15 cases].
Petit P; Blayac JP; Castelnau D; Billet J; Puech R; Pouget R
Encephale; 1987; 13(3):127-30. PubMed ID: 3595515
[TBL] [Abstract][Full Text] [Related]
19. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
20. How much haldol D does Larry really need?
Freudenreich O; McEvoy JP
J Clin Psychiatry; 1995 Jul; 56(7):331-2. PubMed ID: 7615490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
